Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate.
Ann Oncol
; 33(3): 347-349, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34861375
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoadjuvant Therapy
/
Triple Negative Breast Neoplasms
Limits:
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
Italy